{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:07:19Z","timestamp":1765487239431,"version":"3.45.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015582","name":"Ovarian Cancer Academy","doi-asserted-by":"crossref","award":["OC200225","OC200225"],"award-info":[{"award-number":["OC200225","OC200225"]}],"id":[{"id":"10.13039\/100015582","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH\/NCI","award":["P30CA046934","P30CA046934","P30CA046934","P30CA046934"],"award-info":[{"award-number":["P30CA046934","P30CA046934","P30CA046934","P30CA046934"]}]},{"name":"NIH\/NHGRI","award":["R00HG012945"],"award-info":[{"award-number":["R00HG012945"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23137-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:42:05Z","timestamp":1762785725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Benjamin G.","family":"Bitler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nunez-Avellaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian","family":"Behbakht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie R.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian R.","family":"Villagomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"23137_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.20517\/cdr.2021.147","volume":"5","author":"M Ortiz","year":"2022","unstructured":"Ortiz, M., Wabel, E., Mitchell, K. & Horibata, S. Mechanisms of chemotherapy resistance in ovarian cancer. Cancer Drug Resist. 5, 304\u2013316. https:\/\/doi.org\/10.20517\/cdr.2021.147 (2022).","journal-title":"Cancer Drug Resist."},{"key":"23137_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb, P. M. & Jordan, S. J. Global epidemiology of epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 21, 389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"23137_CR3","doi-asserted-by":"publisher","unstructured":"Morand, S., Devanaboyina, M., Staats, H., Stanbery, L. & Nemunaitis, J. Ovarian cancer immunotherapy and personalized medicine. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22126532 (2021).","DOI":"10.3390\/ijms22126532"},{"key":"23137_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1158\/1535-7163.MCT-21-0827","volume":"21","author":"TM Yamamoto","year":"2022","unstructured":"Yamamoto, T. M. et al. Loss of Claudin-4 reduces DNA damage repair and increases sensitivity to PARP inhibitors. Mol. Cancer Ther. 21, 647\u2013657. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0827 (2022).","journal-title":"Mol. Cancer Ther."},{"key":"23137_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov"},{"key":"23137_CR6","doi-asserted-by":"publisher","unstructured":"Lukow, D. A. et al. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies. Dev Cell 56, 2427\u20132439 e2424, (2021). https:\/\/doi.org\/10.1016\/j.devcel.2021.07.009","DOI":"10.1016\/j.devcel.2021.07.009"},{"key":"23137_CR7","doi-asserted-by":"publisher","unstructured":"Ippolito, M. R. et al. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy. Dev Cell 56, 2440\u20132454 e2446, (2021). https:\/\/doi.org\/10.1016\/j.devcel.2021.07.006","DOI":"10.1016\/j.devcel.2021.07.006"},{"key":"23137_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","volume":"612","author":"I Vazquez-Garcia","year":"2022","unstructured":"Vazquez-Garcia, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786. https:\/\/doi.org\/10.1038\/s41586-022-05496-1 (2022).","journal-title":"Nature"},{"key":"23137_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-16-1553","volume":"77","author":"N Andor","year":"2017","unstructured":"Andor, N., Maley, C. C. & Ji, H. P. Genomic instability in cancer: teetering on the limit of tolerance. Cancer Res. 77, 2179\u20132185. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1553 (2017).","journal-title":"Cancer Res."},{"key":"23137_CR10","doi-asserted-by":"publisher","first-page":"1462496","DOI":"10.3389\/fimmu.2024.1462496","volume":"15","author":"M Requesens","year":"2024","unstructured":"Requesens, M., Foijer, F., Nijman, H. W. & de Bruyn, M. Genomic instability as a driver and suppressor of anti-tumor immunity. Front. Immunol. 15, 1462496. https:\/\/doi.org\/10.3389\/fimmu.2024.1462496 (2024).","journal-title":"Front. Immunol."},{"key":"23137_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nm.3984","volume":"22","author":"N Andor","year":"2016","unstructured":"Andor, N. et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat. Med. 22, 105\u2013113. https:\/\/doi.org\/10.1038\/nm.3984 (2016).","journal-title":"Nat. Med."},{"key":"23137_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/2767-9764.CRC-24-0558","volume":"5","author":"FR Villagomez","year":"2025","unstructured":"Villagomez, F. R. et al. Claudin-4 stabilizes the genome via nuclear and cell-Cycle remodeling to support ovarian cancer cell survival. Cancer Res. Commun. 5, 39\u201353. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0558 (2025).","journal-title":"Cancer Res. Commun."},{"key":"23137_CR13","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/2767-9764.CRC-24-0240","volume":"4","author":"FR Villagomez","year":"2024","unstructured":"Villagomez, F. R. et al. Claudin-4 modulates autophagy via SLC1A5\/LAT1 as a mechanism to regulate micronuclei. Cancer Res. Commun. 4, 1625\u20131642. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0240 (2024).","journal-title":"Cancer Res. Commun."},{"key":"23137_CR14","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-24-0240","author":"FR Villagomez","year":"2024","unstructured":"Villagomez, F. R. et al. Claudin-4 modulates autophagy via SLC1A5\/LAT1 as a mechanism to regulate micronuclei. Cancer Res. Commun. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0240 (2024).","journal-title":"Cancer Res. Commun."},{"key":"23137_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/s12885-016-2799-7","volume":"16","author":"DA Hicks","year":"2016","unstructured":"Hicks, D. A. et al. Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration. BMC Cancer. 16, 788. https:\/\/doi.org\/10.1186\/s12885-016-2799-7 (2016).","journal-title":"BMC Cancer"},{"key":"23137_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/ijms12021334","volume":"12","author":"KL Boylan","year":"2011","unstructured":"Boylan, K. L. et al. Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. Int. J. Mol. Sci. 12, 1334\u20131358. https:\/\/doi.org\/10.3390\/ijms12021334 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"23137_CR17","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.1158\/0008-5472.CAN-05-1036","volume":"65","author":"R Agarwal","year":"2005","unstructured":"Agarwal, R., D\u2019Souza, T. & Morin, P. J. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 65, 7378\u20137385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1036 (2005).","journal-title":"Cancer Res."},{"key":"23137_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3892\/or.2015.4037","volume":"34","author":"X Ma","year":"2015","unstructured":"Ma, X. et al. Claudin-4 controls the proliferation, apoptosis, migration and in vivo growth of MCF-7 breast cancer cells. Oncol. Rep. 34, 681\u2013690. https:\/\/doi.org\/10.3892\/or.2015.4037 (2015).","journal-title":"Oncol. Rep."},{"key":"23137_CR19","doi-asserted-by":"publisher","first-page":"e10862","DOI":"10.1016\/j.heliyon.2022.e10862","volume":"8","author":"MC Neville","year":"2022","unstructured":"Neville, M. C., Webb, P. G., Baumgartner, H. K. & Bitler, B. G. Claudin-4 localization in epithelial ovarian cancer. Heliyon 8, e10862. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10862 (2022).","journal-title":"Heliyon"},{"key":"23137_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1749-6632.2000.tb05235.x","volume":"915","author":"S Tsukita","year":"2000","unstructured":"Tsukita, S. & Furuse, M. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann. N Y Acad. Sci. 915, 129\u2013135. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05235.x (2000).","journal-title":"Ann. N Y Acad. Sci."},{"key":"23137_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1158\/1541-7786.MCR-18-0451","volume":"17","author":"C Breed","year":"2019","unstructured":"Breed, C. et al. Ovarian tumor cell expression of Claudin-4 reduces apoptotic response to Paclitaxel. Mol. Cancer Res. 17, 741\u2013750. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0451 (2019).","journal-title":"Mol. Cancer Res."},{"key":"23137_CR22","doi-asserted-by":"publisher","unstructured":"Fujiwara-Tani, R. et al. Claudin-4: A new molecular target for epithelial cancer therapy. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24065494 (2023).","DOI":"10.3390\/ijms24065494"},{"key":"23137_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1747-0285.2010.01061.x","volume":"77","author":"HK Baumgartner","year":"2011","unstructured":"Baumgartner, H. K., Beeman, N., Hodges, R. S. & Neville, M. C. A D-peptide analog of the second extracellular loop of Claudin-3 and \u2013\u20094 leads to mislocalized Claudin and cellular apoptosis in mammary epithelial cells. Chem. Biol. Drug Des. 77, 124\u2013136. https:\/\/doi.org\/10.1111\/j.1747-0285.2010.01061.x (2011).","journal-title":"Chem. Biol. Drug Des."},{"key":"23137_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-19-1057","volume":"18","author":"BT Sawyer","year":"2020","unstructured":"Sawyer, B. T. et al. Targeting fatty acid oxidation to promote Anoikis and inhibit ovarian cancer progression. Mol. Cancer Res. 18, 1088\u20131098. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-1057 (2020).","journal-title":"Mol. Cancer Res."},{"key":"23137_CR25","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/mc.23064","volume":"58","author":"TM Yamamoto","year":"2019","unstructured":"Yamamoto, T. M. et al. Activation of Wnt signaling promotes Olaparib resistant ovarian cancer. Mol. Carcinog. 58, 1770\u20131782. https:\/\/doi.org\/10.1002\/mc.23064 (2019).","journal-title":"Mol. Carcinog."},{"key":"23137_CR26","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1158\/0008-5472.CAN-11-1341","volume":"71","author":"BG Bitler","year":"2011","unstructured":"Bitler, B. G. et al. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res. 71, 6184\u20136194. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1341 (2011).","journal-title":"Cancer Res."},{"key":"23137_CR27","doi-asserted-by":"publisher","DOI":"10.3791\/64606","author":"JM Lanis","year":"2022","unstructured":"Lanis, J. M. et al. Testing cancer immunotherapeutics in a humanized mouse model bearing human tumors. J. Vis. Exp. https:\/\/doi.org\/10.3791\/64606 (2022).","journal-title":"J. Vis. Exp."},{"key":"23137_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.clim.2011.04.002","volume":"140","author":"J Lang","year":"2011","unstructured":"Lang, J., Weiss, N., Freed, B. M., Torres, R. M. & Pelanda, R. Generation of hematopoietic humanized mice in the newborn BALB\/c-Rag2null Il2rgammanull mouse model: a multivariable optimization approach. Clin. Immunol. 140, 102\u2013116. https:\/\/doi.org\/10.1016\/j.clim.2011.04.002 (2011).","journal-title":"Clin. Immunol."},{"key":"23137_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","volume":"18","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. STING: a master regulator in the cancer-immunity cycle. Mol. Cancer. 18, 152. https:\/\/doi.org\/10.1186\/s12943-019-1087-y (2019).","journal-title":"Mol. Cancer"},{"key":"23137_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","volume":"52","author":"JR Hwang","year":"2020","unstructured":"Hwang, J. R., Byeon, Y., Kim, D. & Park, S. G. Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp. Mol. Med. 52, 750\u2013761. https:\/\/doi.org\/10.1038\/s12276-020-0435-8 (2020).","journal-title":"Exp. Mol. Med."},{"key":"23137_CR31","doi-asserted-by":"publisher","first-page":"108440","DOI":"10.1016\/j.mrrev.2022.108440","volume":"790","author":"X Guo","year":"2022","unstructured":"Guo, X. et al. Interplay of cGAS with micronuclei: regulation and diseases. Mutat. Res. Rev. Mutat. Res. 790, 108440. https:\/\/doi.org\/10.1016\/j.mrrev.2022.108440 (2022).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"23137_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465. https:\/\/doi.org\/10.1038\/nature23449 (2017).","journal-title":"Nature"},{"key":"23137_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","volume":"20","author":"M Motwani","year":"2019","unstructured":"Motwani, M., Pesiridis, S. & Fitzgerald, K. A. DNA sensing by the cGAS-STING pathway in health and disease. Nat. Rev. Genet. 20, 657\u2013674. https:\/\/doi.org\/10.1038\/s41576-019-0151-1 (2019).","journal-title":"Nat. Rev. Genet."},{"issue":"e309","key":"23137_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","volume":"55","author":"E Duong","year":"2022","unstructured":"Duong, E. et al. Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8(+) T cell immunity. Immunity 55 (e309), 308\u2013323. https:\/\/doi.org\/10.1016\/j.immuni.2021.10.020 (2022).","journal-title":"Immunity"},{"key":"23137_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481\u2013485. https:\/\/doi.org\/10.1038\/nature09907 (2011).","journal-title":"Nature"},{"key":"23137_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375\u2013386. https:\/\/doi.org\/10.1038\/nri1604 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"23137_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46\u201357. https:\/\/doi.org\/10.1038\/nri3344 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"23137_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13567-020-00793-x","volume":"51","author":"M Dai","year":"2020","unstructured":"Dai, M., Xie, T., Liao, M., Zhang, X. & Feng, M. Systematic identification of chicken type I, II and III interferon-stimulated genes. Vet. Res. 51, 70. https:\/\/doi.org\/10.1186\/s13567-020-00793-x (2020).","journal-title":"Vet. Res."},{"key":"23137_CR39","doi-asserted-by":"publisher","first-page":"110810","DOI":"10.1016\/j.isci.2024.110810","volume":"27","author":"J Lim","year":"2024","unstructured":"Lim, J. et al. Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment. iScience 27, 110810. https:\/\/doi.org\/10.1016\/j.isci.2024.110810 (2024).","journal-title":"iScience"},{"key":"23137_CR40","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 77, e108\u2013e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307 (2017).","journal-title":"Cancer Res."},{"key":"23137_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li, B. et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 17, 174. https:\/\/doi.org\/10.1186\/s13059-016-1028-7 (2016).","journal-title":"Genome Biol."},{"key":"23137_CR42","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407 (2020).","journal-title":"Nucleic Acids Res."},{"key":"23137_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.20892\/j.issn.2095-3941.2023.0440","volume":"21","author":"J Zhang","year":"2024","unstructured":"Zhang, J., Yu, S., Peng, Q., Wang, P. & Fang, L. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies. Cancer Biol. Med. 21, 45\u201364. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0440 (2024).","journal-title":"Cancer Biol. Med."},{"key":"23137_CR44","doi-asserted-by":"publisher","first-page":"216409","DOI":"10.1016\/j.canlet.2023.216409","volume":"577","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. cGAS-STING signaling in the tumor microenvironment. Cancer Lett. 577, 216409. https:\/\/doi.org\/10.1016\/j.canlet.2023.216409 (2023).","journal-title":"Cancer Lett."},{"key":"23137_CR45","doi-asserted-by":"publisher","unstructured":"Tian, Y., Wang, M. L. & Zhao, J. Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity. Viruses 11, (2019). https:\/\/doi.org\/10.3390\/v11020132","DOI":"10.3390\/v11020132"},{"key":"23137_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41392-021-00574-8","volume":"6","author":"X Hui","year":"2021","unstructured":"Hui, X. et al. SARS-CoV-2 promote autophagy to suppress type I interferon response. Signal. Transduct. Target. Ther. 6, 180. https:\/\/doi.org\/10.1038\/s41392-021-00574-8 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"23137_CR47","doi-asserted-by":"publisher","first-page":"748485","DOI":"10.3389\/fcell.2021.748485","volume":"9","author":"K Zhang","year":"2021","unstructured":"Zhang, K., Wang, S., Gou, H., Zhang, J. & Li, C. Crosstalk between autophagy and the cGAS-STING signaling pathway in type I interferon production. Front. Cell. Dev. Biol. 9, 748485. https:\/\/doi.org\/10.3389\/fcell.2021.748485 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"23137_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/15548627.2017.1402992","volume":"14","author":"V Deretic","year":"2018","unstructured":"Deretic, V. & Levine, B. Autophagy balances inflammation in innate immunity. Autophagy 14, 243\u2013251. https:\/\/doi.org\/10.1080\/15548627.2017.1402992 (2018).","journal-title":"Autophagy"},{"key":"23137_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","volume":"567","author":"X Gui","year":"2019","unstructured":"Gui, X. et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature 567, 262\u2013266. https:\/\/doi.org\/10.1038\/s41586-019-1006-9 (2019).","journal-title":"Nature"},{"key":"23137_CR50","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569. https:\/\/doi.org\/10.1038\/s41577-021-00524-z (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"23137_CR51","doi-asserted-by":"publisher","first-page":"1139595","DOI":"10.3389\/fimmu.2023.1139595","volume":"14","author":"Q Lu","year":"2023","unstructured":"Lu, Q., Chen, Y., Li, J., Zhu, F. & Zheng, Z. Crosstalk between cGAS-STING pathway and autophagy in cancer immunity. Front. Immunol. 14, 1139595. https:\/\/doi.org\/10.3389\/fimmu.2023.1139595 (2023).","journal-title":"Front. Immunol."},{"key":"23137_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.chom.2014.01.009","volume":"15","author":"Q Liang","year":"2014","unstructured":"Liang, Q. et al. Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses. Cell. Host Microbe. 15, 228\u2013238. https:\/\/doi.org\/10.1016\/j.chom.2014.01.009 (2014).","journal-title":"Cell. Host Microbe"},{"key":"23137_CR53","doi-asserted-by":"publisher","first-page":"1356369","DOI":"10.3389\/fimmu.2024.1356369","volume":"15","author":"M Schmid","year":"2024","unstructured":"Schmid, M. et al. The interplay between autophagy and cGAS-STING signaling and its implications for cancer. Front. Immunol. 15, 1356369. https:\/\/doi.org\/10.3389\/fimmu.2024.1356369 (2024).","journal-title":"Front. Immunol."},{"key":"23137_CR54","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1016\/j.celrep.2017.11.061","volume":"21","author":"VK Gonugunta","year":"2017","unstructured":"Gonugunta, V. K. et al. Trafficking-Mediated STING degradation requires sorting to acidified endolysosomes and can be targeted to enhance Anti-tumor response. Cell. Rep. 21, 3234\u20133242. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.061 (2017).","journal-title":"Cell. Rep."},{"key":"23137_CR55","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1097\/JS9.0000000000001215","volume":"110","author":"T Jiang","year":"2024","unstructured":"Jiang, T. et al. SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury. Int. J. Surg. 110, 2649\u20132668. https:\/\/doi.org\/10.1097\/JS9.0000000000001215 (2024).","journal-title":"Int. J. Surg."},{"key":"23137_CR56","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/1541-7786.MCR-18-0504","volume":"17","author":"N de Queiroz","year":"2019","unstructured":"de Queiroz, N., Xia, T., Konno, H. & Barber, G. N. Ovarian cancer cells commonly exhibit defective STING signaling which affects sensitivity to viral Oncolysis. Mol. Cancer Res. 17, 974\u2013986. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0504 (2019).","journal-title":"Mol. Cancer Res."},{"key":"23137_CR57","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.18.576263","author":"FR Villagomez","year":"2024","unstructured":"Villagomez, F. R. et al. Claudin-4 modulates autophagy via SLC1A5\/LAT1 as a tolerance mechanism for genomic instability in ovarian cancer. BioRxiv https:\/\/doi.org\/10.1101\/2024.01.18.576263 (2024).","journal-title":"BioRxiv"},{"key":"23137_CR58","doi-asserted-by":"publisher","unstructured":"Wheeler, L. J. et al. Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination. iScience 19, 474\u2013491, (2019). https:\/\/doi.org\/10.1016\/j.isci.2019.07.049","DOI":"10.1016\/j.isci.2019.07.049"},{"key":"23137_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41556-023-01098-9","volume":"25","author":"Y Kuchitsu","year":"2023","unstructured":"Kuchitsu, Y. et al. STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes. Nat. Cell. Biol. 25, 453\u2013466. https:\/\/doi.org\/10.1038\/s41556-023-01098-9 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"23137_CR60","doi-asserted-by":"publisher","first-page":"e21356","DOI":"10.1096\/fj.202002098R","volume":"35","author":"E Li","year":"2021","unstructured":"Li, E. & Ajuwon, K. M. Mechanism of endocytic regulation of intestinal tight junction remodeling during nutrient starvation in jejunal IPEC-J2 cells. FASEB J. 35, e21356. https:\/\/doi.org\/10.1096\/fj.202002098R (2021).","journal-title":"FASEB J."},{"key":"23137_CR61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/nyas.13346","volume":"1397","author":"SM Stamatovic","year":"2017","unstructured":"Stamatovic, S. M., Johnson, A. M., Sladojevic, N., Keep, R. F. & Andjelkovic, A. V. Endocytosis of tight junction proteins and the regulation of degradation and recycling. Ann. N Y Acad. Sci. 1397, 54\u201365. https:\/\/doi.org\/10.1111\/nyas.13346 (2017).","journal-title":"Ann. N Y Acad. Sci."},{"key":"23137_CR62","doi-asserted-by":"publisher","unstructured":"Fedele, A. O. & Proud, C. G. Chloroquine and Bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling. Biosci. Rep. 40 https:\/\/doi.org\/10.1042\/BSR20200905 (2020).","DOI":"10.1042\/BSR20200905"},{"key":"23137_CR63","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1080\/15548627.2023.2165753","volume":"19","author":"L Sedlackova","year":"2023","unstructured":"Sedlackova, L., Kataura, T., Sarkar, S. & Korolchuk, V. I. Metabolic function of autophagy is essential for cell survival. Autophagy 19, 2395\u20132397. https:\/\/doi.org\/10.1080\/15548627.2023.2165753 (2023).","journal-title":"Autophagy"},{"key":"23137_CR64","doi-asserted-by":"publisher","unstructured":"Roux, K. J., Kim, D. I., Burke, B. & May, D. G. BioID: A screen for Protein-Protein interactions. Curr. Protoc. Protein Sci. 91 (19 23 11\u201319 23 15). https:\/\/doi.org\/10.1002\/cpps.51 (2018).","DOI":"10.1002\/cpps.51"},{"key":"23137_CR65","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-2958.2011.07842.x","volume":"82","author":"JS Silverman","year":"2011","unstructured":"Silverman, J. S., Schwartz, K. J., Hajduk, S. L. & Bangs, J. D. Late endosomal Rab7 regulates lysosomal trafficking of endocytic but not biosynthetic cargo in trypanosoma brucei. Mol. Microbiol. 82, 664\u2013678. https:\/\/doi.org\/10.1111\/j.1365-2958.2011.07842.x (2011).","journal-title":"Mol. Microbiol."},{"key":"23137_CR66","doi-asserted-by":"publisher","first-page":"22619","DOI":"10.1073\/pnas.1913509116","volume":"116","author":"A Guillen-Samander","year":"2019","unstructured":"Guillen-Samander, A., Bian, X. & De Camilli, P. PDZD8 mediates a Rab7-dependent interaction of the ER with late endosomes and lysosomes. Proc. Natl. Acad. Sci. U S A. 116, 22619\u201322623. https:\/\/doi.org\/10.1073\/pnas.1913509116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"23137_CR67","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1091\/mbc.E10-06-0495","volume":"21","author":"K Tabata","year":"2010","unstructured":"Tabata, K. et al. Rubicon and PLEKHM1 negatively regulate the endocytic\/autophagic pathway via a novel Rab7-binding domain. Mol. Biol. Cell. 21, 4162\u20134172. https:\/\/doi.org\/10.1091\/mbc.E10-06-0495 (2010).","journal-title":"Mol. Biol. Cell."},{"key":"23137_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tcb.2010.03.002","volume":"20","author":"SF Funderburk","year":"2010","unstructured":"Funderburk, S. F., Wang, Q. J. & Yue, Z. The Beclin 1-VPS34 complex\u2013at the crossroads of autophagy and beyond. Trends Cell. Biol. 20, 355\u2013362. https:\/\/doi.org\/10.1016\/j.tcb.2010.03.002 (2010).","journal-title":"Trends Cell. Biol."},{"key":"23137_CR69","doi-asserted-by":"publisher","first-page":"19338","DOI":"10.1073\/pnas.1010554107","volume":"107","author":"Q Sun","year":"2010","unstructured":"Sun, Q., Westphal, W., Wong, K. N., Tan, I. & Zhong, Q. Rubicon controls endosome maturation as a Rab7 effector. Proc. Natl. Acad. Sci. U S A. 107, 19338\u201319343. https:\/\/doi.org\/10.1073\/pnas.1010554107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"23137_CR70","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1091\/mbc.e08-01-0080","volume":"19","author":"E Itakura","year":"2008","unstructured":"Itakura, E., Kishi, C., Inoue, K. & Mizushima, N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol. Biol. Cell. 19, 5360\u20135372. https:\/\/doi.org\/10.1091\/mbc.e08-01-0080 (2008).","journal-title":"Mol. Biol. Cell."},{"key":"23137_CR71","doi-asserted-by":"publisher","unstructured":"Naslavsky, N. & Caplan, S. The enigmatic endosome - sorting the Ins and outs of endocytic trafficking. J. Cell. Sci. 131 https:\/\/doi.org\/10.1242\/jcs.216499 (2018).","DOI":"10.1242\/jcs.216499"},{"key":"23137_CR72","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/tra.12302","volume":"16","author":"D Dutta","year":"2015","unstructured":"Dutta, D. & Donaldson, J. G. Sorting of Clathrin-Independent cargo proteins depends on Rab35 delivered by Clathrin-Mediated endocytosis. Traffic 16, 994\u20131009. https:\/\/doi.org\/10.1111\/tra.12302 (2015).","journal-title":"Traffic"},{"key":"23137_CR73","doi-asserted-by":"publisher","unstructured":"Taggart, J. C. & Li, G. W. Production of Protein-Complex Components Is Stoichiometric and Lacks General Feedback Regulation in Eukaryotes. Cell Syst 7, 580\u2013589 e584, (2018). https:\/\/doi.org\/10.1016\/j.cels.2018.11.003","DOI":"10.1016\/j.cels.2018.11.003"},{"key":"23137_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41590-018-0287-8","volume":"20","author":"S Srikanth","year":"2019","unstructured":"Srikanth, S. et al. The Ca(2+) sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the Endoplasmic reticulum. Nat. Immunol. 20, 152\u2013162. https:\/\/doi.org\/10.1038\/s41590-018-0287-8 (2019).","journal-title":"Nat. Immunol."},{"key":"23137_CR75","doi-asserted-by":"publisher","first-page":"1087620","DOI":"10.3389\/fimmu.2022.1087620","volume":"13","author":"T Liu","year":"2022","unstructured":"Liu, T. et al. The role of interferons in ovarian cancer progression: hinderer or promoter? Front. Immunol. 13, 1087620. https:\/\/doi.org\/10.3389\/fimmu.2022.1087620 (2022).","journal-title":"Front. Immunol."},{"key":"23137_CR76","doi-asserted-by":"publisher","unstructured":"Shakiba, M. et al. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion. J. Exp. Med. 219 https:\/\/doi.org\/10.1084\/jem.20201966 (2022).","DOI":"10.1084\/jem.20201966"},{"key":"23137_CR77","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1126\/science.1465616","volume":"258","author":"H Mizoguchi","year":"1992","unstructured":"Mizoguchi, H. et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258, 1795\u20131798. https:\/\/doi.org\/10.1126\/science.1465616 (1992).","journal-title":"Science"},{"key":"23137_CR78","first-page":"5610","volume":"53","author":"H Nakagomi","year":"1993","unstructured":"Nakagomi, H. et al. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 53, 5610\u20135612 (1993).","journal-title":"Cancer Res."},{"key":"23137_CR79","first-page":"5613","volume":"53","author":"JH Finke","year":"1993","unstructured":"Finke, J. H. et al. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53, 5613\u20135616 (1993).","journal-title":"Cancer Res."},{"key":"23137_CR80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1365-2141.1994.tb05133.x","volume":"88","author":"M Massaia","year":"1994","unstructured":"Massaia, M., Attisano, C., Beggiato, E., Bianchi, A. & Pileri, A. Correlation between disease activity and T-cell CD3 zeta chain expression in a B-cell lymphoma. Br. J. Haematol. 88, 886\u2013888. https:\/\/doi.org\/10.1111\/j.1365-2141.1994.tb05133.x (1994).","journal-title":"Br. J. Haematol."},{"key":"23137_CR81","first-page":"494","volume":"10","author":"E Rossi","year":"1996","unstructured":"Rossi, E. et al. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia 10, 494\u2013497 (1996).","journal-title":"Leukemia"},{"key":"23137_CR82","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1182\/blood.V88.1.236.236","volume":"88","author":"C Renner","year":"1996","unstructured":"Renner, C. et al. T cells from patients with hodgkin\u2019s disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 88, 236\u2013241 (1996).","journal-title":"Blood"},{"key":"23137_CR83","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1365-2141.2003.04044.x","volume":"120","author":"GF Torelli","year":"2003","unstructured":"Torelli, G. F. et al. Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. Br. J. Haematol. 120, 201\u2013208. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04044.x (2003).","journal-title":"Br. J. Haematol."},{"key":"23137_CR84","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1054\/bjoc.2001.1847","volume":"84","author":"DD Taylor","year":"2001","unstructured":"Taylor, D. D., Bender, D. P., Gercel-Taylor, C., Stanson, J. & Whiteside, T. L. Modulation of TcR\/CD3-zeta chain expression by a Circulating factor derived from ovarian cancer patients. Br. J. Cancer. 84, 1624\u20131629. https:\/\/doi.org\/10.1054\/bjoc.2001.1847 (2001).","journal-title":"Br. J. Cancer"},{"key":"23137_CR85","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1172\/JCI1518","volume":"101","author":"H Rabinowich","year":"1998","unstructured":"Rabinowich, H. et al. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J. Clin. Invest. 101, 2579\u20132588. https:\/\/doi.org\/10.1172\/JCI1518 (1998).","journal-title":"J. Clin. Invest."},{"key":"23137_CR86","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.5808\/gi.23009","volume":"21","author":"JH Lee","year":"2023","unstructured":"Lee, J. H. et al. Single-cell RNA sequencing identifies distinct transcriptomic signatures between PMA\/ionomycin- and alphaCD3\/alphaCD28-activated primary human T cells. Genomics Inf. 21, e18. https:\/\/doi.org\/10.5808\/gi.23009 (2023).","journal-title":"Genomics Inf."},{"key":"23137_CR87","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","volume":"181","author":"KJ Oestreich","year":"2008","unstructured":"Oestreich, K. J., Yoon, H., Ahmed, R. & Boss, J. M. NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 181, 4832\u20134839. https:\/\/doi.org\/10.4049\/jimmunol.181.7.4832 (2008).","journal-title":"J. Immunol."},{"key":"23137_CR88","doi-asserted-by":"publisher","first-page":"100146","DOI":"10.1016\/j.cellin.2024.100146","volume":"3","author":"R Liu","year":"2024","unstructured":"Liu, R., Li, H. F. & Li, S. PD-1-mediated Inhibition of T cell activation: mechanisms and strategies for cancer combination immunotherapy. Cell. Insight. 3, 100146. https:\/\/doi.org\/10.1016\/j.cellin.2024.100146 (2024).","journal-title":"Cell. Insight"},{"key":"23137_CR89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","volume":"9","author":"H Cheon","year":"2023","unstructured":"Cheon, H., Wang, Y., Wightman, S. M., Jackson, M. W. & Stark, G. R. How cancer cells make and respond to interferon-I. Trends Cancer. 9, 83\u201392. https:\/\/doi.org\/10.1016\/j.trecan.2022.09.003 (2023).","journal-title":"Trends Cancer"},{"key":"23137_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12865-015-0108-x","volume":"16","author":"W Lin","year":"2015","unstructured":"Lin, W. et al. Morphological change of CD4(+) T cell during contact with DC modulates T-cell activation by accumulation of F-actin in the immunology synapse. BMC Immunol. 16, 49. https:\/\/doi.org\/10.1186\/s12865-015-0108-x (2015).","journal-title":"BMC Immunol."},{"key":"23137_CR91","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41467-021-22708-w","volume":"12","author":"M Bleu","year":"2021","unstructured":"Bleu, M. et al. PAX8 and MECOM are interaction partners driving ovarian cancer. Nat. Commun. 12, 2442. https:\/\/doi.org\/10.1038\/s41467-021-22708-w (2021).","journal-title":"Nat. Commun."},{"key":"23137_CR92","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.neo.2022.100866","volume":"36","author":"A Salvi","year":"2023","unstructured":"Salvi, A. et al. PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome. Neoplasia 36, 100866. https:\/\/doi.org\/10.1016\/j.neo.2022.100866 (2023).","journal-title":"Neoplasia"},{"key":"23137_CR93","doi-asserted-by":"publisher","first-page":"784947","DOI":"10.3389\/fonc.2021.784947","volume":"11","author":"MM Cogels","year":"2021","unstructured":"Cogels, M. M. et al. Humanized mice as a valuable Pre-Clinical model for cancer immunotherapy research. Front. Oncol. 11, 784947. https:\/\/doi.org\/10.3389\/fonc.2021.784947 (2021).","journal-title":"Front. Oncol."},{"key":"23137_CR94","doi-asserted-by":"publisher","first-page":"37080","DOI":"10.18632\/oncotarget.26354","volume":"9","author":"K Sun","year":"2018","unstructured":"Sun, K. et al. A comparative Pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models. Oncotarget 9, 37080\u201337096. https:\/\/doi.org\/10.18632\/oncotarget.26354 (2018).","journal-title":"Oncotarget"},{"key":"23137_CR95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"RE Tay","year":"2021","unstructured":"Tay, R. E., Richardson, E. K. & Toh, H. C. Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. 28, 5\u201317. https:\/\/doi.org\/10.1038\/s41417-020-0183-x (2021).","journal-title":"Cancer Gene Ther."},{"key":"23137_CR96","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","volume":"25","author":"ML Axelrod","year":"2019","unstructured":"Axelrod, M. L., Cook, R. S., Johnson, D. B. & Balko, J. M. Biological consequences of MHC-II expression by tumor cells in cancer. Clin. Cancer Res. 25, 2392\u20132402. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3200 (2019).","journal-title":"Clin. Cancer Res."},{"key":"23137_CR97","doi-asserted-by":"publisher","first-page":"E9942","DOI":"10.1073\/pnas.1707658114","volume":"114","author":"H Schuster","year":"2017","unstructured":"Schuster, H. et al. The immunopeptidomic landscape of ovarian carcinomas. Proc. Natl. Acad. Sci. U S A. 114, E9942\u2013E9951. https:\/\/doi.org\/10.1073\/pnas.1707658114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"23137_CR98","doi-asserted-by":"publisher","unstructured":"Tegeler, C. M. et al. HLA-DR presentation of the tumor antigen MSLN associates with clinical outcome of ovarian cancer patients. Cancers (Basel). 14 https:\/\/doi.org\/10.3390\/cancers14092260 (2022).","DOI":"10.3390\/cancers14092260"},{"key":"23137_CR99","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1038\/ncomms10582","volume":"7","author":"DB Johnson","year":"2016","unstructured":"Johnson, D. B. et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy. Nat. Commun. 7, 10582. https:\/\/doi.org\/10.1038\/ncomms10582 (2016).","journal-title":"Nat. Commun."},{"key":"23137_CR100","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/2326-6066.CIR-15-0243","volume":"4","author":"A Forero","year":"2016","unstructured":"Forero, A. et al. Expression of the MHC class II pathway in Triple-Negative breast cancer tumor cells is associated with a good prognosis and infiltrating lymphocytes. Cancer Immunol. Res. 4, 390\u2013399. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0243 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"23137_CR101","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun, C., Mezzadra, R. & Schumacher, T. N. Regulation and function of the PD-L1 checkpoint. Immunity 48, 434\u2013452. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.014 (2018).","journal-title":"Immunity"},{"key":"23137_CR102","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.3892\/ol.2019.10903","volume":"18","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y., Fang, Y. C. & Li, J. PD-L1 expression levels on tumor cells affect their immunosuppressive activity. Oncol. Lett. 18, 5399\u20135407. https:\/\/doi.org\/10.3892\/ol.2019.10903 (2019).","journal-title":"Oncol. Lett."},{"key":"23137_CR103","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-022-10404-x","volume":"23","author":"K Alwosaibai","year":"2023","unstructured":"Alwosaibai, K. et al. PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers. BMC Cancer. 23, 13. https:\/\/doi.org\/10.1186\/s12885-022-10404-x (2023).","journal-title":"BMC Cancer"},{"key":"23137_CR104","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.1921445117","volume":"117","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 Blockade therapy. Proc. Natl. Acad. Sci. U S A. 117, 6640\u20136650. https:\/\/doi.org\/10.1073\/pnas.1921445117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"23137_CR105","doi-asserted-by":"publisher","first-page":"e1408747","DOI":"10.1080\/2162402X.2017.1408747","volume":"7","author":"S Du","year":"2018","unstructured":"Du, S. et al. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth. Oncoimmunology 7, e1408747. https:\/\/doi.org\/10.1080\/2162402X.2017.1408747 (2018).","journal-title":"Oncoimmunology"},{"key":"23137_CR106","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","volume":"162","author":"S Kleffel","year":"2015","unstructured":"Kleffel, S. et al. Melanoma Cell-Intrinsic PD-1 receptor functions promote tumor growth. Cell 162, 1242\u20131256. https:\/\/doi.org\/10.1016\/j.cell.2015.08.052 (2015).","journal-title":"Cell"},{"key":"23137_CR107","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3389\/fimmu.2018.01774","volume":"9","author":"H Yao","year":"2018","unstructured":"Yao, H., Wang, H., Li, C., Fang, J. Y. & Xu, J. Cancer Cell-Intrinsic PD-1 and implications in combinatorial immunotherapy. Front. Immunol. 9, 1774. https:\/\/doi.org\/10.3389\/fimmu.2018.01774 (2018).","journal-title":"Front. Immunol."},{"key":"23137_CR108","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez, K. J., Allen, B. M. & Spitzer, M. H. Systemic immunity in cancer. Nat. Rev. Cancer. 21, 345\u2013359. https:\/\/doi.org\/10.1038\/s41568-021-00347-z (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"23137_CR109","doi-asserted-by":"publisher","unstructured":"Yang, W. et al. T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution. J. Exp. Clin. Cancer Res. 43 https:\/\/doi.org\/10.1186\/s13046-024-02960-w (2024).","DOI":"10.1186\/s13046-024-02960-w"},{"key":"23137_CR110","doi-asserted-by":"publisher","first-page":"e173290","DOI":"10.1001\/jamaoncol.2017.3290","volume":"3","author":"OTT Analysis","year":"2017","unstructured":"Analysis, O. T. T. Dose-Response association of CD8\u2009+\u2009Tumor-Infiltrating lymphocytes and survival time in High-Grade serous ovarian cancer. JAMA Oncol. 3, e173290. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3290 (2017).","journal-title":"JAMA Oncol."},{"key":"23137_CR111","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3389\/fimmu.2019.01719","volume":"10","author":"A Xia","year":"2019","unstructured":"Xia, A., Zhang, Y., Xu, J., Yin, T. & Lu, X. J. T cell dysfunction in cancer immunity and immunotherapy. Front. Immunol. 10, 1719. https:\/\/doi.org\/10.3389\/fimmu.2019.01719 (2019).","journal-title":"Front. Immunol."},{"key":"23137_CR112","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1126\/science.2371564","volume":"249","author":"SJ Frank","year":"1990","unstructured":"Frank, S. J. et al. Structural mutations of the T cell receptor zeta chain and its role in T cell activation. Science 249, 174\u2013177. https:\/\/doi.org\/10.1126\/science.2371564 (1990).","journal-title":"Science"},{"key":"23137_CR113","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Signal. Transduct. Target. Ther. 6, 412. https:\/\/doi.org\/10.1038\/s41392-021-00823-w (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"23137_CR114","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/21541248.2018.1463895","volume":"11","author":"FR Villagomez","year":"2020","unstructured":"Villagomez, F. R., Medina-Contreras, O., Cerna-Cortes, J. F. & Patino-Lopez, G. The role of the oncogenic Rab35 in cancer invasion, metastasis, and immune evasion, especially in leukemia. Small GTPases. 11, 334\u2013345. https:\/\/doi.org\/10.1080\/21541248.2018.1463895 (2020).","journal-title":"Small GTPases"},{"key":"23137_CR115","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.18632\/oncotarget.12739","volume":"8","author":"D Ribatti","year":"2017","unstructured":"Ribatti, D. The concept of immune surveillance against tumors. The first theories. Oncotarget 8, 7175\u20137180. https:\/\/doi.org\/10.18632\/oncotarget.12739 (2017).","journal-title":"Oncotarget"},{"key":"23137_CR116","doi-asserted-by":"publisher","unstructured":"Chauveau, A. et al. Visualization of T Cell Migration in the Spleen Reveals a Network of Perivascular Pathways that Guide Entry into T Zones. Immunity 52, 794\u2013807 e797, (2020). https:\/\/doi.org\/10.1016\/j.immuni.2020.03.010","DOI":"10.1016\/j.immuni.2020.03.010"},{"key":"23137_CR117","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.4049\/jimmunol.180.5.3122","volume":"180","author":"SB Wong","year":"2008","unstructured":"Wong, S. B., Bos, R. & Sherman, L. A. Tumor-specific CD4\u2009+\u2009T cells render the tumor environment permissive for infiltration by low-avidity CD8\u2009+\u2009T cells. J. Immunol. 180, 3122\u20133131. https:\/\/doi.org\/10.4049\/jimmunol.180.5.3122 (2008).","journal-title":"J. Immunol."},{"key":"23137_CR118","doi-asserted-by":"publisher","first-page":"e0180644","DOI":"10.1371\/journal.pone.0180644","volume":"12","author":"A Barinov","year":"2017","unstructured":"Barinov, A. et al. CD4\/CD8\/Dendritic cell complexes in the spleen: CD8\u2009+\u2009T cells can directly bind CD4\u2009+\u2009T cells and modulate their response. PLoS One. 12, e0180644. https:\/\/doi.org\/10.1371\/journal.pone.0180644 (2017).","journal-title":"PLoS One"},{"key":"23137_CR119","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.celrep.2012.08.006","volume":"2","author":"S Ugel","year":"2012","unstructured":"Ugel, S. et al. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell. Rep. 2, 628\u2013639. https:\/\/doi.org\/10.1016\/j.celrep.2012.08.006 (2012).","journal-title":"Cell. Rep."},{"key":"23137_CR120","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.4049\/jimmunol.176.4.2085","volume":"176","author":"VP Makarenkova","year":"2006","unstructured":"Makarenkova, V. P., Bansal, V., Matta, B. M., Perez, L. A. & Ochoa, J. B. CD11b+\/Gr-1\u2009+\u2009myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176, 2085\u20132094. https:\/\/doi.org\/10.4049\/jimmunol.176.4.2085 (2006).","journal-title":"J. Immunol."},{"key":"23137_CR121","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41418-018-0251-z","volume":"26","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. STING directly activates autophagy to tune the innate immune response. Cell. Death Differ. 26, 1735\u20131749. https:\/\/doi.org\/10.1038\/s41418-018-0251-z (2019).","journal-title":"Cell. Death Differ."},{"key":"23137_CR122","doi-asserted-by":"publisher","first-page":"e112387","DOI":"10.15252\/embj.2022112387","volume":"42","author":"W Wan","year":"2023","unstructured":"Wan, W. et al. STING directly recruits WIPI2 for autophagosome formation during STING-induced autophagy. EMBO J. 42, e112387. https:\/\/doi.org\/10.15252\/embj.2022112387 (2023).","journal-title":"EMBO J."},{"key":"23137_CR123","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tcb.2016.11.011","volume":"27","author":"G Hewitt","year":"2017","unstructured":"Hewitt, G., Korolchuk, V. I. & Repair, Reuse, R. The expanding role of autophagy in genome maintenance. Trends Cell. Biol. 27, 340\u2013351. https:\/\/doi.org\/10.1016\/j.tcb.2016.11.011 (2017).","journal-title":"Trends Cell. Biol."},{"key":"23137_CR124","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521\u2013534. https:\/\/doi.org\/10.1016\/j.cell.2008.11.044 (2009).","journal-title":"Cell"},{"key":"23137_CR125","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ijc.33300","volume":"148","author":"X Guo","year":"2021","unstructured":"Guo, X., Dai, X., Wu, X., Cao, N. & Wang, X. Small but strong: mutational and functional landscapes of micronuclei in cancer genomes. Int. J. Cancer. 148, 812\u2013824. https:\/\/doi.org\/10.1002\/ijc.33300 (2021).","journal-title":"Int. J. Cancer"},{"key":"23137_CR126","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/2159-8290.CD-23-1073","volume":"14","author":"M Di Bona","year":"2024","unstructured":"Di Bona, M. & Bakhoum, S. F. Micronuclei and cancer. Cancer Discov. 14, 214\u2013226. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1073 (2024).","journal-title":"Cancer Discov"},{"key":"23137_CR127","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.eclinm.2024.102629","volume":"72","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial. EClinicalMedicine 72, 102629. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102629 (2024).","journal-title":"EClinicalMedicine"},{"key":"23137_CR128","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","volume":"381","author":"A Gonzalez-Martin","year":"2019","unstructured":"Gonzalez-Martin, A. et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl. J. Med. 381, 2391\u20132402. https:\/\/doi.org\/10.1056\/NEJMoa1910962 (2019).","journal-title":"N Engl. J. Med."},{"key":"23137_CR129","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/s41598-019-38534-6","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models. Sci. Rep. 9, 1853. https:\/\/doi.org\/10.1038\/s41598-019-38534-6 (2019).","journal-title":"Sci. Rep."},{"key":"23137_CR130","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/0008-5472.CAN-18-1003","volume":"79","author":"J Shen","year":"2019","unstructured":"Shen, J. et al. PARPi triggers the STING-Dependent immune response and enhances the therapeutic efficacy of immune checkpoint Blockade independent of BRCAness. Cancer Res. 79, 311\u2013319. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1003 (2019).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23137-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:02:34Z","timestamp":1763172154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23137-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23137"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23137-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human stem cells were isolated from clinically rejected cord blood units from the University of Colorado Cord Blood bank (Clinimmune Labs, Aurora, CO). Murine studies were approved by the University of Colorado IACUC (Protocol #374).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"39257"}}